TY - JOUR
T1 - Evaluation of polypectomy quality indicators of large nonpedunculated colorectal polyps in a nonexpert, bowel cancer screening cohort
AU - Meulen, L.W.T.
AU - van der Zander, Q.E.W.
AU - Bogie, R.M.
AU - Keulen, E.T.P.
AU - van Nunen, A.B.
AU - Winkens, B.
AU - Straathof, J.W.A.
AU - Hoge, C.V.
AU - de Ridder, R.
AU - Moons, L.M.G.
AU - Masclee, A.A.M.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Background and Aims: With the introduction of the national bowel cancer screening program, the detection of sessile and flat colonic lesions >= 20 mmin size, defined as large nonpedunculated colorectal polyps (LNPCPs), has increased. The aim of this study was to examine the quality of endoscopic treatment of LNPCPs in the Dutch screening program.Methods: This investigation comprised 2 related, but separate, substudies (1 with a cross-sectional design and 1 with a longitudinal design). The first examined prevalence and characteristics of LNPCPs in data from the national Dutch screening cohort from February 2014 until January 2017. The second, with screening data from 5 endoscopy units in the Southern part of the Netherlands from February 2014 until August 2015, examined performance on important quality indicators (technical and clinical successes, recurrence rate, adverse event rate, and surgery referral rate). All patients were part of the national Dutch screening cohort.Results: In the national cohort, an LNPCP was detected in 8% of participants. Technical and clinical success decreased with increasing LNPCP size, from 93% and 96% in 20- to 29-mm lesions to 85% and 86% in 30- to 39-mm lesions and to 74% and 81% in >= 40-mm lesions (P <.001; P = .034). The cumulative recurrence rate at 12 months increased with LNPCP size, from 9% to 22% and 26% in the respective size groups (P = .095). The adverse event rate was 5%. The overall surgical referral rate for noninvasive LNPCPs was 7%.Conclusions: In this performance of 2 substudies, it was shown that quality parameters for endoscopic resection of large polyps in the Dutch screening cohort are not reached, especially in >= 30-mm polyps. Endoscopic resection of large polyps could benefit from additional training, quality monitoring, and centralization either within or between centers.
AB - Background and Aims: With the introduction of the national bowel cancer screening program, the detection of sessile and flat colonic lesions >= 20 mmin size, defined as large nonpedunculated colorectal polyps (LNPCPs), has increased. The aim of this study was to examine the quality of endoscopic treatment of LNPCPs in the Dutch screening program.Methods: This investigation comprised 2 related, but separate, substudies (1 with a cross-sectional design and 1 with a longitudinal design). The first examined prevalence and characteristics of LNPCPs in data from the national Dutch screening cohort from February 2014 until January 2017. The second, with screening data from 5 endoscopy units in the Southern part of the Netherlands from February 2014 until August 2015, examined performance on important quality indicators (technical and clinical successes, recurrence rate, adverse event rate, and surgery referral rate). All patients were part of the national Dutch screening cohort.Results: In the national cohort, an LNPCP was detected in 8% of participants. Technical and clinical success decreased with increasing LNPCP size, from 93% and 96% in 20- to 29-mm lesions to 85% and 86% in 30- to 39-mm lesions and to 74% and 81% in >= 40-mm lesions (P <.001; P = .034). The cumulative recurrence rate at 12 months increased with LNPCP size, from 9% to 22% and 26% in the respective size groups (P = .095). The adverse event rate was 5%. The overall surgical referral rate for noninvasive LNPCPs was 7%.Conclusions: In this performance of 2 substudies, it was shown that quality parameters for endoscopic resection of large polyps in the Dutch screening cohort are not reached, especially in >= 30-mm polyps. Endoscopic resection of large polyps could benefit from additional training, quality monitoring, and centralization either within or between centers.
KW - ENDOSCOPIC MUCOSAL RESECTION
KW - ADENOMA RECURRENCE
KW - EUROPEAN-SOCIETY
KW - LOCAL RECURRENCE
KW - COLONIC EMR
KW - NEOPLASIA
KW - PREVALENCE
KW - MANAGEMENT
KW - MORPHOLOGY
U2 - 10.1016/j.gie.2021.06.008
DO - 10.1016/j.gie.2021.06.008
M3 - Article
C2 - 34139253
SN - 0016-5107
VL - 94
SP - 1085-1095.e2
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 6
ER -